These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


81 related items for PubMed ID: 9301671

  • 1. Inhibition of melanoma cell binding to type IV collagen by analogs of cell adhesion regulator.
    Lauer JL, Furcht LT, Fields GB.
    J Med Chem; 1997 Sep 12; 40(19):3077-84. PubMed ID: 9301671
    [Abstract] [Full Text] [Related]

  • 2. An all-D amino acid peptide model of alpha1(IV)531-543 from type IV collagen binds the alpha3beta1 integrin and mediates tumor cell adhesion, spreading, and motility.
    Li C, McCarthy JB, Furcht LT, Fields GB.
    Biochemistry; 1997 Dec 09; 36(49):15404-10. PubMed ID: 9398270
    [Abstract] [Full Text] [Related]

  • 3. Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells.
    Shahan TA, Ziaie Z, Pasco S, Fawzi A, Bellon G, Monboisse JC, Kefalides NA.
    Cancer Res; 1999 Sep 15; 59(18):4584-90. PubMed ID: 10493512
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthetic peptides inhibit adhesion of human tumor cells to extracellular matrix proteins.
    DeRoock IB, Pennington ME, Sroka TC, Lam KS, Bowden GT, Bair EL, Cress AE.
    Cancer Res; 2001 Apr 15; 61(8):3308-13. PubMed ID: 11309285
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Interaction between endothelial cells and basement membrane components. In vitro studies on endothelial cell adhesion to collagen types I, III, IV and high molecular weight fragments of IV.
    Rixen H, Kirkpatrick CJ, Schmitz U, Ruchatz D, Mittermayer C.
    Exp Cell Biol; 1989 Apr 15; 57(6):315-23. PubMed ID: 2535276
    [Abstract] [Full Text] [Related]

  • 8. Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulation.
    Dutta AS, Gormley JJ, Coath M, Hassall L, Hayward CF, Gellert PR, Kittlety RS, Alcock PJ, Ferguson R, Halterman T, Jamieson A, Moors JA, Moores JM, Rees A, Wood LJ, Reilly CF, Haworth D.
    J Pept Sci; 2000 Aug 15; 6(8):398-412. PubMed ID: 10969869
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Peptide array-based interaction assay of solid-bound peptides and anchorage-dependant cells and its effectiveness in cell-adhesive peptide design.
    Kato R, Kaga C, Kunimatsu M, Kobayashi T, Honda H.
    J Biosci Bioeng; 2006 Jun 15; 101(6):485-95. PubMed ID: 16935250
    [Abstract] [Full Text] [Related]

  • 11. Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.
    Haier J, Nasralla M, Nicolson GL.
    Br J Cancer; 1999 Aug 15; 80(12):1867-74. PubMed ID: 10471033
    [Abstract] [Full Text] [Related]

  • 12. Role of the extracellular matrix proteins in the resistance of SP6.5 uveal melanoma cells toward cisplatin.
    Bérubé M, Talbot M, Collin C, Paquet-Bouchard C, Germain L, Guérin SL, Petitclerc E.
    Int J Oncol; 2005 Feb 15; 26(2):405-13. PubMed ID: 15645125
    [Abstract] [Full Text] [Related]

  • 13. Type IV collagen and corneal epithelial adhesion and migration. Effects of type IV collagen fragments and synthetic peptides on rabbit corneal epithelial cell adhesion and migration in vitro.
    Cameron JD, Skubitz AP, Furcht LT.
    Invest Ophthalmol Vis Sci; 1991 Sep 15; 32(10):2766-73. PubMed ID: 1894474
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptide.
    Dutta AS, Crowther M, Gormley JJ, Hassall L, Hayward CF, Gellert PR, Kittlety RS, Alcock PJ, Jamieson A, Moores JM, Rees A, Wood LJ, Reilly CF, Haworth D.
    J Pept Sci; 2000 Jul 15; 6(7):321-41. PubMed ID: 10946997
    [Abstract] [Full Text] [Related]

  • 16. Integrin-like substrate adhesion in RTG-2 cells, a fibroblastic cell line derived from rainbow trout.
    Reinhart B, Lee LE.
    Cell Tissue Res; 2002 Feb 15; 307(2):165-72. PubMed ID: 11845323
    [Abstract] [Full Text] [Related]

  • 17. A synthetic peptide from the heparin-binding domain III (repeats III4-5) of fibronectin promotes stress-fibre and focal-adhesion formation in melanoma cells.
    Moyano JV, Maqueda A, Albar JP, Garcia-Pardo A.
    Biochem J; 2003 Apr 15; 371(Pt 2):565-71. PubMed ID: 12519080
    [Abstract] [Full Text] [Related]

  • 18. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD, Smith ER, Yang DH, Roland IH, Vanderveer L, Cohen C, Hamilton TC, Godwin AK, Xu XX.
    Cancer; 2002 Oct 15; 95(8):1802-15. PubMed ID: 12365030
    [Abstract] [Full Text] [Related]

  • 19. Studies of the local conformational properties of the cell-adhesion domain of collagen type IV in synthetic heterotrimeric peptides.
    Saccà B, Fiori S, Moroder L.
    Biochemistry; 2003 Apr 01; 42(12):3429-36. PubMed ID: 12653546
    [Abstract] [Full Text] [Related]

  • 20. A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells.
    Pasco S, Han J, Gillery P, Bellon G, Maquart FX, Borel JP, Kefalides NA, Monboisse JC.
    Cancer Res; 2000 Jan 15; 60(2):467-73. PubMed ID: 10667602
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.